SEARCH

SEARCH BY CITATION

References

  • 1
    Okuda K, Ohnishi K, Kimura K, Matsutani S, Sumida M, Goto N, Musha H, et al. Incidence of portal thrombosis in liver cirrhosis. An angiographic study in 708 patients. Gastroenterology 1985; 89:279286.MEDLINE
  • 2
    Orozco H, Takahashi T, Mercado MA, Garcia-Tsao G, Gonzalez-Lopez-Lira A, Hernandez-Ortiz J. Postoperative portal vein obstruction in patients with idiopathic portal hypertension. J Clin Gastroenterol 1990; 12:607.MEDLINE
  • 3
    Belli L, Romani F, Sansalone CV, Aseni P, Rondinara G. Portal thrombosis in cirrhotics. A retrospective analysis. Ann Surg 1986; 203:286291.MEDLINE
  • 4
    Sarfeh IJ. Portal vein thrombosis associated with cirrhosis: clinical importance. Arch Surg 1979; 114:902905.MEDLINE
  • 5
    Gayowski TJ, Marino IR, Doyle HR, Echeverri L, Mieles L, Todo S, Wagener M, et al. A high incidence of native portal vein thrombosis in veterans undergoing liver transplantation. J Surg Res 1996; 60:333338.MEDLINE
  • 6
    Violi F, Ferro D, Basili S, D'Angelo A, Mazzola G, Quintarelli C, Cordoa C. Relation between lupus anticoagulant and splanchnic venous thrombosis in cirrhosis of the liver. Br Med J 1994; 309:239240.
  • 7
    Valla D, Denninger MH, Delvigne JM, Rueff B, Benhamou JP. Portal vein thrombosis with ruptured oesophageal varices as presenting manifestation of hereditary protein C deficiency. Gut 1988; 29:856859.MEDLINE
  • 8
    Majluf-Cruz A, Hurtado-Monroy R, Sansores-Garcia L, Labardini-Mendez J. The incidence of protein C deficiency in thrombosis-related portal hypertension. Am J Gastroenterol 1996; 91:976980.MEDLINE
  • 9
    Godeau B, Leroy-Matheron C, Gouault-Heilmann M, Schaeffer A. A case of portal thrombosis associated with protein S deficiency. J Hepatol 1993; 18:258.MEDLINE
  • 10
    Bouaniche M, Guedon C, Borg JY, Zalar A, Ducrotte P, Lerebours E. Thrombose portale relevant un syndrome des antiphospholipides. Deux cas. Gastroenterol Clin Biol 1996; 20:897900.MEDLINE
  • 11
    Yonemitsu Y, Yanaga K, Matsumata T, Sugimachi K. Portal vein thrombosis due to antithrombin III deficiency. A case report. Angiology 1995; 46:10431047.MEDLINE
  • 12
    Romero Gomez M, Suarez Garcia E, Lopez Lacomba D, Grande L, Marchante I, Castro Fernandez M. Antiphospholipid antibodies: relationship to portal vein thrombosis in cirrhotic liver patients. Hepatology 1998; 4(Part 2):453A.
  • 13
    Markis M, Rosendaal FR, Preston FE. Familial thrombophilia: genetic risk and management. J Int Med Suppl 1997; 740:915.
  • 14
    Bertina M. Factor V Leiden and other coagulation factor mutation affecting thrombotic risk. Clin Chem 1997; 43:16781683.MEDLINE
  • 15
    Poort SR, Rosendaal FR, Reitsma PH, Bertina RM. A common genetic variation in the 3′-untranslated region of the prothrombin gene is associated with elevated plasma prothrombin levels and an increase in venous thrombosis. Blood 1996; 15:36983703.
  • 16
    Biousse V, Conard J, Brouzes C, Horellou MH, Ameri A, Bousser MG. Frequency of the 20210 G[RIGHTWARDS ARROW]>A mutation in the 3′-untranslated region of the prothrombin gene in 35 cases of cerebral venous thrombosis. Stroke 1998; 29:13981400.MEDLINE
  • 17
    Kapur RK, Millis LA, Spitzer SG, Hultin MB. A prothrombin gene mutation is significantly associated with venous thrombosis. Arterioscler Thromb Vasc Biol 1997; 17:28752879.MEDLINE
  • 18
    Brown K, Luddington R, Williamson D, Baker P, Baglin T. Risk of venous thromboembolism associated with a G to A transition at position 20210 in the 3 untranslated region of the prothrombin gene. Br J Haematol 1997; 98:907909.MEDLINE
  • 19
    Margaglione M, Brancaccio V, Giuliani N, D'Andrea G, Cappucci G, Iannaccone L, Vecchione G, et al. Increased risk for venous thrombosis in carriers of the prothrombin G[RIGHTWARDS ARROW]A20210 gene variant. Ann Intern Med 1998; 129:8993.MEDLINE
  • 20
    Margaglione M, D'Andrea G, d'Addedda M, Giuliani N, Cappucci G, Iannaccone L, Vecchione G, et al. The methylenetetrahydrofolate reductase TT677 genotype is associated with venous thrombosis independently of the coexistence of the FV Leiden and the prothrombin A20210 mutation. Thromb Haemost 1998; 79:907911.MEDLINE
  • 21
    Margaglione M, Di Minno G, Grandone E, Vecchione G, Celentano E, Cappucci G, Giordano M, et al. Raised plasma fibrinogen concentrations in subjects attending a metabolic ward. Relation to family history and vascular risk factors. Thromb Haemost 1995; 73:579583.MEDLINE
  • 22
    Koeleman BPC, Reitsma PH, Allaart CF, Bertina RM. Activated protein C resistance has an additional risk factor for thrombosis in protein C–deficient families. Blood 1994; 84:10311035.MEDLINE
  • 23
    Margaglione M, D'Andrea G, Cappucci G, Grandone E, Giuliani N, Colaizzo D, Vecchione G, et al. Detection of factor V Leiden mutation using SSCP. Thromb Haemost 1996; 76:814815.MEDLINE
  • 24
    De Franchis R, Mancini FP, D'Angelo A, Sebastio G, Fermo I, de Stefano V, Margaglione M, et al. Elevated total plasma homocysteine and C[RIGHTWARDS ARROW]T mutation of 5,10 methylenetetrahydrofolate reductase gene in thrombotic vascular disease. Am J Hum Genet 1996; 59:262264.MEDLINE
  • 25
    Grandone E, Margaglione M, Colaizzo D, Cappucci G, Paladini D, Martinelli P, Montanaro S, et al. Factor V Leiden, C[RIGHTWARDS ARROW]T MTHFR polymorphism and genetic susceptibility to preeclampsia. Thromb Haemost 1997; 77:10521054.MEDLINE
  • 26
    Mahmoud AEA, Elias E, Beauchamp N, Wilde JT. Prevalence of the factor V Leiden mutation in hepatic and portal vein thrombosis. Gut 1997; 40:798800.MEDLINE
  • 27
    Biron C, Andreani H, Blanc P, Ramos J, Ducos J, Guigue H, et al. Prevalence of antiphospholipid antibodies in patients with chronic liver disease related to alcohol or hepatitis C virus: correlation with liver injury. J Lab Clin Med 1998; 131:243250.MEDLINE
  • 28
    Prieto J, Yuste JR, Beloqui O, Civeira MP, Riezu JI, Agiurre B, et al. Anticardiolipin antibodies in chronic hepatitis C: implication of hepatitis C virus as the cause of the antiphospholipid syndrome. Hepatology 1996; 23:199204.MEDLINE
  • 29
    Leroy V, Arvieux J, Jacob MC, Maynard-Muet M, Baud M, Zarski JP. Prevalence and significance of anticardiolipin, anti-beta2 glycoprotein I and anti-prothrombin antibodies in chronic hepatitis. Br J Hematol 1998; 101:468474.
  • 30
    Bertina RM, Koeleman PC, Koster T, Rosendaal FR, Dirven RJ, de Ronde H, van der Velden PA, et al. Mutation in blood coagulation factor V associated with resistance to activated protein C. Nature 1994; 369:6467.MEDLINE
  • 31
    Frosst P, Blom HK, Milos R, Goyette P, Sheppard CA, Matthews RG, Boers GHJ, et al. A candidate genetic risk factor for vascular disease: a common mutation in methylenetetrahydrofolate reductase. Nat Genet 1995; 10:111113.MEDLINE
  • 32
    den Heijer M, Koster T, Blom HJ, Bos GM, Briet E, Reitsma PH, Vandenbroucke JP, et al. Hyperhomocysteinemia as a risk factor for deep-vein thrombosis. N Engl J Med 1996; 334:759762.MEDLINE
  • 33
    Fermo I, Vigano'-D'Angelo S, Paroni R, Mazzola G, Calori G, D'Angelo A. Prevalence of moderate hyperhomocysteinemia in patients with early onset venous and arterial occlusive disease. Ann Intern Med 1995; 123:747753.MEDLINE
  • 34
    Levoir D, Aubertin JM, Alhenc-Gelas M, Bloch F, Becheur H, Petite JP. Une nouvelle cause hereditaire de thrombose portale: la resistance anormale a la proteine C activee par mutation Arg506[RIGHTWARDS ARROW]Gln du gene du facteur V. Gastroenterol Clin Biol 1995; 19:729731.MEDLINE
  • 35
    Janssen HLA, Meinardi J, Vleggaar FP, Haagsma EB, Rosendaal FR, van Hoek B. Factor V Leiden mutation, prothrombin gene mutation and deficiencies in coagulation inhibitors associated with Budd-Chiari syndrome and portal vein thrombosis. Hepatology 1998; 4(Part 2):452A.
  • 36
    Chamouard P, Pencreach E, Maloisel F, Grunebaum L, Ardizzone JF, Meyer A, Gaub MP, et al. Frequent factor II G20210A mutation in idiopathic portal vein thrombosis. Gastroenterology 1999; 116:144148.MEDLINE
  • 37
    Prisco D, Gori AM, Pepe G, Marcucci R, Brunelli T, Giusti B, Gensini GF, et al. Factor II 2021′ G[RIGHTWARDS ARROW]A polymorphism associated to factor V Leiden: a report of two thrombophilic families. Thromb Res 1998; 89:249252.MEDLINE
  • 38
    Ferraresi P, Marchetti G, Legnani C, Cavallari E, Castoldi E, Mascoli F, Ardissino D, et al. The heterozygous 20210 G/A prothrombin gene is associated with early venous thrombosis in inherited thrombophilias and is not increased in frequency in artery disease. Arterioscler Thromb Vasc Biol 1997; 17:24182422.MEDLINE
  • 39
    Ehrenforth S, Ludwig G, Klinke S, Krause M, Scharrer I, Nowak-Gottl U. The prothrombin 20210 A allele is frequently coinherited in young carriers of the factors V Arg 506 to Gln mutation with venous thrombophilia. Blood 1998; 91:22092210.MEDLINE